Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (330)	1/5/2001 3:06:29 PM
From: tuck	Read Replies (1) of 1784

tom, Pretty noticeable delayed reaction, eh? A Fool thinks this will eventually end in licensing: biz.yahoo.com Again, ABI likely to get the short end here, requiring a hit to earnings sometime. Thus all the earnings growth ratios go out the window. I imagine ABI has some foreign exposure, and we saw that whack TECH for a few cents shortfall. I think it will get worse for ABI, and am lowering my secondary nibble target to $50. On the positive side, monetary damages should be limited. Conversely, the clearing up of this issue makes the upcoming APBiotech IPO look a lot more promising. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next